Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Cited by (1,009)

Items 501–600 of 1,009

1. A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
   Aaya M. Nassar, Ibrahim M. Ibrahim, Fatma G. Amin, Merna Magdy, Ahmed M. Elgharib, Eman B. Azzam, Filopateer Nasser, Kirllos Yousry, Israa Mohamed Shamkh, Samah M. Mahdy et al. · 2021 · Molecules
2. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues
   Sinae Kim, Tam T. Nguyen, Afeisha S. Taitt, Hyunjhung Jhun, Ho-Young Park, Sung‐Han Kim, Yong‐Gil Kim, Eun Young Song, Young-Min Lee, Ho-Kee Yum et al. · 2021 · Immune Network
3. Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools
   Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone · 2024 · International Journal of Molecular Sciences
4. Structure and inhibition of SARS-CoV-2 spike refolding in membranes
   Michael W. Grunst, Zhuan Qin, Esteban Dodero‐Rojas, Shilei Ding, Jérémie Prévost, Yaozong Chen, Yanping Hu, Marzena Pazgier, Shenping Wu, Xuping Xie et al. · 2024 · Science
5. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches
   Jyotisha, Samayaditya Singh, Insaf Ahmed Qureshi · 2020 · Journal of Biomolecular Structure and Dynamics
6. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
   Subodh Kumar, Phulen Sarma, Hardeep Kaur, Manisha Prajapat, Anusuya Bhattacharyya, Pramod Avti, Nishant Sehkhar, Harpinder Kaur, Seema Bansal, Saniya Mahendiratta et al. · 2021 · Tissue and Cell
7. The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions
   José Caetano Silva-Filho, Cynthia Germoglio Farias de Melo, Janaína Lima de Oliveira · 2020 · Medical Hypotheses
8. Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis
   Ashish Kumar, Anil Arora, Praveen Sharma, Shrihari Anil Anikhindi, Naresh Kumar Bansal, Vikas Singla, Shivam Khare, Abhishyant Srivastava · 2020 · Indian Journal of Gastroenterology
9. DockCoV2: a drug database against SARS-CoV-2
   Ting-Fu Chen, Yu‐Chuan Chang, Yi Hsiao, Ko-Han Lee, Yu-Chun Hsiao, Yu-Hsiang Lin, Yi-Chin Ethan Tu, Hsuan‐Cheng Huang, Chien‐Yu Chen, Hsueh‐Fen Juan · 2020 · Nucleic Acids Research
10. Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease
    Eduardo Tejera, Cristian Robert Munteanu, Andrés López‐Cortés, Alejandro Cabrera‐Andrade, Yunierkis Pérez‐Castillo · 2020 · Molecules
11. Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor
    Elhan Taka, Sema Zeynep Yilmaz, Mert Gölcük, Ceren Kılınç, Umut Aktas, Ahmet Yıldız, Mert Gür · 2021 · The Journal of Physical Chemistry B
12. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development
    Medha Karnik, Narasimha Murthy Beeraka, Chinnappa A. Uthaiah, Suma Maduvanahalli Nataraj, Anjali Devi S. Bettadapura, Gjumrakch M. Aliev, SubbaRao V. Madhunapantula · 2021 · Molecular Neurobiology
13. A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
    Magnus S. Bauer, Sophia Gruber, Adina Hausch, Priscila da Silva Figueiredo Celestino Gomes, Lukas F. Milles, Thomas Nicolaus, Leonard C. Schendel, Pilar López Navajas, Erik Procko, Daniel Lietha et al. · 2022 · Proceedings of the National Academy of Sciences
14. Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction
    Shuang Wang, Junchao Wang, Xiaojuan Yu, Wen Jiang, Shuo Chen, Rongjuan Wang, Mingzhu Wang, Shasha Jiao, Wenbo Wang, Wenbo Wang et al. · 2022 · Communications Biology
15. In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding
    Neil Bate, Christos G. Savva, P.C.E. Moody, Edward A. Brown, Siân E. Evans, Jonathan K. Ball, John W. R. Schwabe, Julian E. Sale, Nicholas P.J. Brindle · 2022 · PLoS Pathogens
16. Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis
    Soohyun Kim, Jong‐Hwan Lee · 2022 · BioChip Journal
17. Nanotraps for the containment and clearance of SARS-CoV-2
    Min Chen, Jillian Rosenberg, Xiaolei Cai, A. Lee, Jiu-Yun Shi, Mindy Nguyen, T. Wignakumar, Vikranth R. Mirle, Arianna Edobor, John F. Fung et al. · 2021 · bioRxiv
18. Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2
    Titilayo Omolara Johnson, Abayomi Emmanuel Adegboyega, Opeyemi Iwaloye, Abiodun Omokehinde Eseola, Winfried Plass, Boluwatife Afolabi, Damilare Rotimi, Eman Ibrahim Ahmed, Ashraf Albrakati, Gaber El‐Saber Batiha et al. · 2021 · Journal of Pharmacological Sciences
19. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
    Vanna Sanna, Sandro Satta, Tzung K. Hsiai, Mario Sechi · 2022 · European Journal of Medicinal Chemistry
20. Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective
    Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen · 2020 · Frontiers in Immunology
21. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations
    Rakesh Sarkar, Suvrotoa Mitra, Pritam Chandra, Priyanka Saha, Anindita Banerjee, Shanta Dutta, Mamta Chawla‐Sarkar · 2021 · Archives of Virology
22. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients
    Laksmi Wulandari, Berliana Hamidah, Cennikon Pakpahan, Nevy Shinta Damayanti, Neneng Dewi Kurniati, Christophorus Oetama Adiatmaja, Monica Rizky Wigianita, Soedarsono Soedarsono, Dominicus Husada, Damayanti Tinduh et al. · 2021 · Human Genomics
23. Bioactive peptides produced by engineered probiotics and other food-grade bacteria: A review
    Haydee Eliza Romero‐Luna, Adrián Hernández‐Mendoza, Aaron Fernando González-Córdova, Audry Gustavo Peredo-Lovillo · 2021 · Food Chemistry X
24. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
    Sandipan Chakraborty · 2020 · Biochemical and Biophysical Research Communications
25. Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
    Kuan‐Ting Liu, Yi-Ju Han, Guan-Hong Wu, Kuan-Ying Arthur Huang, Peng-Nien Huang · 2022 · Viruses
26. Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides
    Marijn N. Maas, Jordi C. J. Hintzen, Philipp M. G. Löffler, Jasmin Mecinović · 2021 · Chemical Communications
27. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy
    Xin Wu Zeng, Lingfang Li, Jing Lin, Xinlei Li, Bin Liu, Yang Kong, Shunze Zeng, Jianhua Du, Huahong Xiao, Tao Zhang et al. · 2020 · Antibody Therapeutics
28. Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system
    Ryosuke Fujita, Masato Hino, Takeru Ebihara, Takumi Nagasato, Akitsu Masuda, Jae Man Lee, Tsuguru Fujii, Hiroaki Mon, Kohei Kakino, Ryo Nagai et al. · 2020 · Biochemical and Biophysical Research Communications
29. Neuropathogenesis of SARS-CoV-2 infection
    Shumayila Khan, James Gomes · 2020 · eLife
30. Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function
    Alejandro Berrío, Valerie Gartner, Gregory A. Wray · 2020 · PeerJ
31. Molecular recognition of SARS-CoV-2 spike glycoprotein: quantum chemical hot spot and epitope analyses
    Chiduru Watanabe, Yoshio Okiyama, Shigenori Tanaka, Kaori Fukuzawa, Teruki Honma · 2021 · Chemical Science
32. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
    Lin Wang, Ye Xiang · 2020 · Viruses
33. Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
    M. Mor, M. Werbner, J. Alter, Modi Safra, Elad Chomsky, J. C. Lee, Smadar Hada-Neeman, Ksenia Polonsky, C. Nowell, A. Clark et al. · 2021 · PLoS Pathogens
34. The SARS-CoV-2 spike protein is vulnerable to moderate electric fields
    Claudia R. Arbeitman, Pablo Rojas, Pedro Ojeda-May, Martı́n E. Garcia · 2021 · Nature Communications
35. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
    Jie Mei, Yatong Zhou, Xinping Yang, Fan Zhang, Xiufeng Liu, Boyang Yu · 2021 · Journal of Ethnopharmacology
36. Mechanical activation of spike fosters SARS-CoV-2 viral infection
    Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Dan Yao, Yufei Gao, Jia Liu, Hui Chen, Lu Qiao, Tenny Mudianto et al. · 2021 · Cell Research
37. Scanning the RBD-ACE2 molecular interactions in Omicron variant
    Soumya Lipsa Rath, Aditya Kumar Padhi, Nabanita Mandal · 2021 · Biochemical and Biophysical Research Communications
38. SARS-CoV-2 drug resistance and therapeutic approaches
    Sania Batool, Santosh Chokkakula, Ju Hwan Jeong, Yun Hee Baek, Min‐Suk Song · 2025 · Heliyon
39. Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
    Akanksha Rajput, Anamika Thakur, Adhip Mukhopadhyay, Sakshi Kamboj, Amber Rastogi, Sakshi Gautam, Harvinder Jassal, Manoj Kumar · 2021 · Computational and Structural Biotechnology Journal
40. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
    Cuiqing Ma, Shan Su, Jiachao Wang, Lin Wei, Lanying Du, Shibo Jiang · 2020 · Microbes and Infection
41. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
    Sara Lega, Samuele Naviglio, Stefano Volpi, Alberto Tommasini · 2020 · Vaccines
42. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression
    Zhilan Zhang, Lin Li, Mengyuan Li, Xiaosheng Wang · 2020 · Computational and Structural Biotechnology Journal
43. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
    Sameer Kumar Malladi, Randhir Singh, Suman Pandey, Savitha Gayathri, Kawkab Kanjo, Shahbaz Ahmed, M. S. A. Alam Khan, Parismita Kalita, Nidhi Girish, Aditya Upadhyaya et al. · 2020 · Journal of Biological Chemistry
44. Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge
    Chaogeng Zhu, Guiyun He, Qinqin Yin, Lin Zeng, Xiangli Ye, Yongzhong Shi, Wei Xu · 2021 · Journal of Medical Virology
45. The molecular basis for SARS-CoV-2 binding to dog ACE2
    Zengyuan Zhang, Yanfang Zhang, Kefang Liu, Yan Li, Qiong Lu, Qingling Wang, Yuqin Zhang, Liang Wang, Hanyi Liao, Anqi Zheng et al. · 2021 · Nature Communications
46. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation
    Pallab Kar, Vijay Kumar, Balachandar Vellingiri, Arnab Sen, Nishika Jaishee, Akash Anandraj, Himani Malhotra, Subires Bhattacharyya, Subhasish Mukhopadhyay, Masako Kinoshita et al. · 2020 · Journal of Biomolecular Structure and Dynamics
47. Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics
    Hariharan Sivaraman, Shi Yin Er, Yeu Khai Choong, Edem Gavor, Jayaraman Sivaraman · 2020 · The Annual Review of Pharmacology and Toxicology
48. In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
    Tianzi Wei, Hao Wang, Xueqing Wu, Yi Lu, Shenghui Guan, Fengquan Dong, Chenle Dong, Guli Zhu, Yuzhou Bao, Jian Zhang et al. · 2020 · Chinese Journal of Integrative Medicine
49. Predicting susceptibility to SARS‐CoV‐2 infection based on structural differences in ACE2 across species
    Matthew R. Alexander, Clara T. Schoeder, Jacquelyn Ann Brown, Charles D Smart, Christopher W. Moth, John P. Wikswo, John A. Capra, Jens Meiler, Wenbiao Chen, Meena S. Madhur · 2020 · The FASEB Journal
50. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study
    Luigi Rosa, Giovanni Luigi Tripepi, Enrico Naldi, Marina Aimati, Stefano Santangeli, Francesco Venditto, Marcello Caldarelli, Piera Valenti · 2021 · Journal of Clinical Medicine
51. Lymphopenia in Covid-19: A single center retrospective study of 589 cases
    El Aidouni Ghizlane, Manal Merbouh, El Kaouini Abderrahim, Abdelilah El Rhalete, Mohammed Maarad, Rajae Alkouh, Mohammed Amine Bouazzaoui, Houssam Bkiyar, Naïma Abda, Housni Brahim · 2021 · Annals of Medicine and Surgery
52. Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
    Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian · 2022 · Reviews in Medical Virology
53. Protective neutralizing epitopes in SARS‐CoV‐2
    Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
54. Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s
    Linjie Li, Pu Han, Baihan Huang, Yufeng Xie, Weiwei Li, Di Zhang, Pengcheng Han, Zepeng Xu, Bin Bai, Jingya Zhou et al. · 2022 · Cell Discovery
55. The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells
    Christopher B. Forsyth, Lijuan Zhang, Abhinav Bhushan, Barbara A. Swanson, Li Zhang, João I. Mamede, Robin M. Voigt, Maliha W. Shaikh, Phillip A. Engen, Ali Keshavarzian · 2022 · Microorganisms
56. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
    Cristina Adriana Dehelean, Voichița Elena Lăzureanu, Dorina Elena Coricovac, Marius Mioc, Roxana Oancea, Iasmina Marcovici, Iulia Pînzaru, Codruţa Şoica, Aristidis Michael Tsatsakis, Octavian Marius Cretu · 2020 · Journal of Clinical Medicine
57. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
    Dibya Ghimire, Yang Han, Maolin Lu · 2022 · Viruses
58. Advanced Pulmonary and Cardiac Support of COVID-19 Patients
    Keshava Rajagopal, Steven P. Keller, Bindu H. Akkanti, Christian Bime, Pranav Loyalka, Faisal Habib Cheema, Joseph Bertram Zwischenberger, Aly El Banayosy, Federico Pappalardo, Mark S. Slaughter et al. · 2020 · Circulation Heart Failure
59. Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein
    Sharuk L. Khan, Falak A. Siddiqui · 2020 · Archives of Pharmacology and Therapeutics
60. Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach
    Abozar Ghorbani, Fatemeh Zare, Sima Sazegari, Alireza Afsharifar, Mohammad Hadi Eskandari, Ali Pormohammad · 2020 · New Microbes and New Infections
61. Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners
    Ioana Roxana Bordea, Edit Xhajanka, Sebastian Candrea, Simion Bran, Florin Gligor Onisor, Alessio Danilo Inchingolo, Giuseppina Malcangi, Van Hung Pham, Angelo Michele Inchingolo, Antônio Scarano et al. · 2020 · Microorganisms
62. Development of Metal Complexes for Treatment of Coronaviruses
    Hany M. Abd El‐Lateef, Tarek El‐Dabea, Mai M. Khalaf, Ahmed M. Abu‐Dief · 2022 · International Journal of Molecular Sciences
63. An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
    Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, Behnaz Bakhshandeh, Ramezan Ali Taheri, Hoorieh Soleimanjahi, Reza Zolfaghari Emameh · 2023 · International Immunopharmacology
64. An Overview of the Crystallized Structures of the SARS-CoV-2
    Mihaela Ileana Ionescu · 2020 · The Protein Journal
65. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
    Szu‐Wei Huang, Sheng‐Fan Wang · 2021 · International Journal of Molecular Sciences
66. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
    Eileen M. McGowan, Nahal Haddadi, Najah Therese Nassif, Yiguang Lin · 2020 · International Journal of Molecular Sciences
67. Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction
    Changdong Lin, Yue Li, MengYa Yuan, Mengwen Huang, Cui Liu, Chenjian Gu, Xingchao Pan, YaTing Wen, Xinyi Xu, Chenqi Xu et al. · 2021 · Signal Transduction and Targeted Therapy
68. Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection
    Rohini Dwivedi, Priyanka Samanta, Poonam Sharma, Fuming Zhang, Sushil K. Mishra, Pavel Kucheryavy, Seon Beom Kim, AyoOluwa O. Aderibigbe, Robert J. Linhardt, Ritesh Tandon et al. · 2021 · Journal of Biological Chemistry
69. Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
    Erik Laurini, Domenico Marson, Suzana Aulić, Alice Fermeglia, Sabrina Pricl · 2021 · Scientific Reports
70. PWM2Vec: An Efficient Embedding Approach for Viral Host Specification from Coronavirus Spike Sequences
    Sarwan Ali, Babatunde Bello, Prakash Chourasia, Ria Thazhe Punathil, Yijing Zhou, Murray Patterson · 2022 · Biology
71. Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
    Honghui Liu, Lili Wu, Bo Liu, Ke Xu, Wenwen Lei, Jianguo Deng, Xiaoyu Rong, Pei Du, Lebing Wang, Dongbin Wang et al. · 2023 · Cell Reports Medicine
72. A Triple-Targeted Rutin-Based Self-Assembled Delivery Vector for Treating Ischemic Stroke by Vascular Normalization and Anti-Inflammation via ACE2/Ang1-7 Signaling
    Tingkui Zhao, Fujin He, Keqing Zhao, Lin Yuxia, Huanyu Li, X A Liu, Juan Cen, Shaofeng Duan · 2023 · ACS Central Science
73. Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants
    Linjie Li, Kaiyuan Shi, Yuhang Gu, Zepeng Xu, Chang Shu, Dedong Li, Junqing Sun, Mengqing Cong, Xiaomei Li, Xin Zhao et al. · 2024 · Structure
74. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens
    Yoya Vashi, Vipin Jagrit, Sachin Kumar · 2020 · Infection Genetics and Evolution
75. Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
    Sebastian J. Pomplun · 2020 · RSC Medicinal Chemistry
76. Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
    Roger Yazbeck, Simone E. Jaenisch, Catherine Anne Abbott · 2021 · Biochemical Pharmacology
77. Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein
    Yan Wang, Zhen Wu, Wenhua Hu, Piliang Hao, Shuang Yang · 2021 · ACS Omega
78. Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies
    Wen‐Yeh Hsieh, Cheng‐Han Lin, Tzu‐Ching Lin, Chao‐Hsu Lin, Hui‐Fang Chang, Chin-Hung Tsai, Hsi‐Tien Wu, Chih‐Sheng Lin · 2021 · Diagnostics
79. Emerging roles for endogenous retroviruses in immune epigenetic regulation*
    Carmen A. Buttler, Edward B. Chuong · 2021 · Immunological Reviews
80. Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19
    Dylan C. Sarver, Guang William Wong · 2020 · Biochemical and Biophysical Research Communications
81. Modelling the structural and reactivity landscapes of tucatinib with special reference to its wavefunction-dependent properties and screening for potential antiviral activity
    Ali Alsalme, Thangaiyan Pooventhiran, Nabil Al‐Zaqri, D. Jagadeeswara Rao, Siriki Srinivasa Rao, Renjith Thomas · 2020 · Journal of Molecular Modeling
82. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2
    Shagufta, Irshad Ahmad · 2021 · European Journal of Medicinal Chemistry
83. COVID-19 in-vitro Diagnostics: State-of-the-Art and Challenges for Rapid, Scalable, and High-Accuracy Screening
    Zeina S. Habli, Sahera A. Saleh, Hassan Zaraket, Massoud L. Khraiche · 2021 · Frontiers in Bioengineering and Biotechnology
84. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species
    Hong-Liang Zhang, Yuming Li, Jing Sun, Yu-Yuan Zhang, Tong-Yun Wang, Ming-xia Sun, Meng-Hang Wang, Yue-Lin Yang, Xiao-Liang Hu, Yan‐Dong Tang et al. · 2021 · Journal of Biological Chemistry
85. Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021
    Kun Xu, Lianpan Dai, George F. Gao · 2021 · International Immunology
86. Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
    Douglas F. Lake, Alexa J. Roeder, Erin J. Kaleta, Paniz Jasbi, Kirsten Pfeffer, Calvin Koelbela, Sivakumar Periasamy, Natalia A. Kuzmina, Alexander A. Bukreyev, Thomas E. Grys et al. · 2021 · Journal of Clinical Virology
87. The SARS-CoV-2 spike protein binds and modulates estrogen receptors
    Óscar Solís, Andrea R. Beccari, Daniela Iaconis, Carmine Talarico, Camilo A. Ruiz-Bedoya, Jerome C. Nwachukwu, Annamaria Cimini, Vanessa Castelli, Riccardo Bertini, Monica Montopoli et al. · 2022 · Science Advances
88. What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms
    Sawsan Aboul‐Fotouh, Ahmed N. Mahmoud, Esraa M. Elnahas, Mohamed Z. Habib, Sahar M. Abdelraouf · 2023 · Virology Journal
89. Vaccines and Therapies in Development for SARS-CoV-2 Infections
    David Bin-Chia Wu, Raghuram Koganti, Upendra Pradeep Lambe, Tejabhiram Yadavalli, Shyam Sundar Nandi, Deepak Shukla · 2020 · Journal of Clinical Medicine
90. Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
    Michael J. Edwards, Katrin Anne Becker, Barbara Gripp, Markus Hoffmann, Simone Keitsch, Barbara Wilker, Matthias Soddemann, Anne Gulbins, Elisa Carpinteiro, Sameer H. Patel et al. · 2020 · Journal of Biological Chemistry
91. Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry
    S. Perez-Miller, M. Patek, Aubin Moutal, Paz Duran, C. R. Cabel, C. Thorne, S. K. Campos, R. Khanna · 2021 · ACS Chemical Neuroscience
92. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
    Philipp Jörrißen, Paula Schütz, Matthias Weiand, Richard Vollenberg, Inga Marie Schrempf, Kevin Ochs, Christopher Frömmel, Phil‐Robin Tepasse, Hartmut Schmidt, Andree Zibert · 2021 · Frontiers in Immunology
93. Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor
    Muhammad Suleman, Qudsia Yousafi, Javaid Ali, Syed Shujait Ali, Zahid Hussain, Shahid Ali, Muhammad Waseem, Arshad Iqbal, Sajjad Ahmad, Abbas Khan et al. · 2021 · Computers in Biology and Medicine
94. Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions
    Mary Hongying Cheng, James Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, Moshe Arditi, İvet Bahar · 2022 · iScience
95. The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19
    Deng, Pingji, Ke, Zunqiong, Ying, Binwu, Qiao, Bin, Yuan, Leyong · 2020 · Clinica Chimica Acta
96. E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody
    Sandipan Chakraborty · 2021 · International Immunopharmacology
97. Allosteric inhibitors of the main protease of SARS-CoV-2
    Subodh Kumar Samrat, Jimin Xu, Xuping Xie, Eleonora Gianti, Haiying Chen, Jing Zou, Jason G. Pattis, Khaled M. Elokely, Hyun Lee, Zhong Li et al. · 2022 · Antiviral Research
98. In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
    İsmail Çeli̇k, Meryem Erol, Zekeriya Düzgün · 2021 · Molecular Diversity
99. Evolution of the SARS‐CoV ‐2 proteome in three dimensions (3D) during the first 6 months of the COVID ‐19 pandemic
    Joseph H. Lubin, Christine Zardecki, Elliott M. Dolan, Changpeng Lu, Zhuofan Shen, Shuchismita Dutta, John Westbrook, Brian P. Hudson, David S. Goodsell, Jonathan K. Williams et al. · 2021 · Proteins Structure Function and Bioinformatics
100. Experimental Models of COVID-19
     Luis A. Caldera-Crespo, Michael John Paidas, Sabita Roy, Carl Ivan Schulman, Norma Sue Kenyon, Sylvia Daunert, Arumugam Radhakrishnan Jayakumar · 2022 · Frontiers in Cellular and Infection Microbiology